The COX-2/PGE2 axis directly upregulates p-gp and breast cancer resistance protein (BCRP) transporter levels, and COX-2 inhibition was shown to increase the intracellular concentration of the chemotherapeutic agent mitomycin C in human BlCa cell lines [106,121]. Here, PTGER2 is linked to bladder transitional cell carcinoma.